In the past few years, our award-winning deals have been recognized within the industry. Take a closer look at the
breadth and depth of our experience by viewing details by industry, sector or transaction type.
In the past 12 months, we have been involved in over 99 transactions, 17 as lead or co-lead manager, representing
gross proceeds of more than $14.1 billion, not including structured products.
Tangible Equity Units
Raymond James was a Joint Bookrunning Manager on the Initial Public Offering of GFL Environmental Inc.,
raising US$1,425,000,000 Common Shares and US$775,000 Tangible Equity Units. GFL is the fourth largest
diversified environmental services company in North America, providing a comprehensive line of non-hazardous
solid waste management, infrastructure & soil remediation and liquid waste management services through its
platform of facilities throughout Canada and in 23 states in the United States.
Raymond James was co-lead manager on the Bought Deal Public Offering of Trust Units of True North Commercial
REIT, raising $80.52 million, which includes the exercise of the full over-allotment option. The REIT is an
unincorporated, open-ended real estate investment trust established under the laws of the Province of
Ontario. The REIT currently owns and operates a portfolio of 45 commercial properties consisting of
approximately 3.7 million square feet in urban and select secondary markets across Canada.
Raymond James was a co-lead manager on the Cross-Border Follow-On Offering of Zymeworks Inc., raising
approximately US$201 million, which includes the exercise of the full over-allotment option. Zymeworks Inc.
is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein
therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.
Raymond James was Co-Lead on the Overnight Marketed Public Offering of IMV Inc., raising approx. $29
million, which includes the exercise of the full over-allotment option. IMV Inc. is a clinical stage
biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and
more widely available to people facing cancer and other serious diseases.
Raymond James was lead manager on the Upsized Bought Deal Private Placement of Common Shares of Blackline
Safety Corp., raising $31.625 million, which includes the exercise of the full over-allotment option.
Blackline Safety is a global connected safety technology leader, providing comprehensive live-monitoring and
wireless gas detection, to help teams working in hazardous environments respond to emergencies in real-time
and manage efficient evacuations, accounting for everyone’s safety along the way.
Subscription Reciepts & Extendible Convertible Unsecured Debentures
Raymond James was lead manager on the Bought Deal Offering of Subscription Receipts and Extendible
Convertible Unsecured Debentures of Baylin Technologies Inc., raising $40.25 million, which includes the
exercise of the full over-allotment option. Baylin is a diversified leading global wireless technology
management company, that focuses on research, design, development, manufacturing and sales of passive and
active radio frequency products and services. Baylin aspires to meet customers' needs and anticipate the
direction of the market.